Regen BioPharma Inc (RGBP)

[cvinvestor]

Good morning Sage. Stock prices are dependent on a lot of factors. Some overvalue companies, some undervalue companies and some are at the prey of organized manipulation. Check out PPCH stock price variance over the past 5 days. 1,000% price change low to high as a result of a $4,000 ad campaign with the right group. No drastic change in company over that period, just a well orchestrated release, repackaging of info that started what might be a pump and dump or what might be a new price base because of sector potential.

I can't tell you where RGBP is. I definitely feel that if the plan of RGBP spin off with immediate follow up of HemaX FDA approval had occurred as planned last year, we wouldn't be in this price range. Unfortunately, it must be noted that the CEO David Koos has a troublesome business past with creating companies that didn't perform according to the expectations of PRs released. It may be a while before that past can be shed. The price can change very quickly with even one large investment company as the avg shares traded here daily amount to less than $50,000/day.

Sustained, concrete facts and progress - the FDA approval of HemaXellerate to human trials and the auto designation of Orphan Drug status will definitely impact this stock price, but right now we haven't had the big outside investment money and our past is not pretty, so the price is lacking. Ichims remember are less than 2 months hired, big money is cautious and wants the facts and performance which Koos cannot give, so until RGBP lays new ground with the Ichims living up to their name and patents get noticed as being important. Remember, this is a penny stock, a small fish in a big ocean of thousands of scientists. Big money doesn't drudge the penny stock charts I wouldn't think, but they will keep their eyes on patents and FDA clinical trial approvals. I believe that is when the game will change and IF, IF RGBP can follow through and get HemaX and dCellVax or another treatment to human trials sometime in 2015, we might not be in penny land much longer.